Katherine Winkel

Katherine Winkel, MBA, is a seasoned marketing professional specializing in biotechnologies and oncology. Currently serving as Senior Director of clonoSEQ Marketing & Sales Training at Adaptive Biotechnologies Corp., Katherine leads marketing initiatives and sales training for a proprietary minimal residual disease test, focusing on strategic product launches and omnichannel campaigns. Previous experience includes roles as Director of clonoSEQ Marketing and Senior Product Marketing Manager at CTI BioPharma, where Katherine successfully developed marketing plans and commercialization strategies for diagnostic and therapeutic products. Katherine's educational background includes an MBA from Washington University in St. Louis and multiple degrees from Syracuse University, highlighting a strong foundation in marketing, public affairs, and psychology.